Table 2

Heart rate variability (five minute resting study and deep breathing test) in healthy controls and in patients with Huntington's disease

Controls (n=60)Patients (total) (n=18)E-HD group (n=9)M-HD group (n=9)
All HRV indices (except the LF/HF ratio) were log transformed. The values given are means (SD).
E-HD, Early stage Huntington's disease; M-HD, middle stage Huntington's disease. HRV, heart rate variability; HRr, resting heart rate; CVr, CVd, coefficient of variation; RMSSDr, RMSSDd, root mean square of successive differences; MCR, mean circular resultant; LF, low frequency; HF, high frequency.
Statistical comparison was by one way analysis of variance with post hoc comparison of means by Duncan's multiple range test: *p<0.05 compared with healthy controls; †p<0.05 compared with the E-HD group.
5 min resting study
    HRr (beats/min)73.1 (11.1)78.7 (12.0)78.2 (10.5)79.2 (13.9)
    CVr (%)0.65 (0.19)0.58 (0.21)0.69 (0.15)0.46 (0.20)*†
    RMSSDr (ms)1.43 (0.28)1.32 (0.35)1.44 (0.30)1.20 (0.38)*
    LF power (ms2)2.87 (0.45)2.88 (0.41)3.08 (0.32)2.68 (0.39)
    HF power (ms2)2.66 (0.46)2.53 (0.64)2.84 (0.35)2.20 (0.71)*†
    LF/HF ratio2.33 (2.19)3.15 (2.45)2.07 (1.09)4.23 (2.97)*
Deep breathing test
    CVd (%)0.88 (0.19)0.83 (0.19)0.92 (0.09)0.74 (0.22)*
    RMSSDd (ms)1.58 (0.24)1.51 (0.25)1.60 (0.15)1.42 (0.30)
    MCR−1.38 (0.25)−1.51 (0.28)−1.42 (0.22)−1.60 (0.32)*